The Mounjaro Patient Assistance Program: Eligibility, Application Process, and Cost-Saving Options
The cost of prescription medications can be a major concern for many patients, especially with newer therapies like Mounjaro (tirzepatide). While the medication has shown significant benefits for managing type 2 diabetes, its high retail price can make access challenging for people without adequate insurance coverage.
To help eligible patients afford treatment, Eli Lilly offers assistance programs designed for different financial situations. The Lilly Cares Foundation Patient Assistance Program provides free medication to qualifying individuals who cannot afford Mounjaro, while the Mounjaro Savings Card helps commercially insured patients reduce their out-of-pocket costs.
Understanding the differences between these programs, who qualifies, and how to apply can help patients identify the most suitable option for lowering their medication expenses.
Lilly Cares Foundation vs. Mounjaro Savings Card: Understanding the Difference
Eli Lilly provides two separate affordability programs, but they are designed for different groups of patients.
Lilly Cares Foundation Patient Assistance Program
The Lilly Cares Foundation Patient Assistance Program is a charitable assistance program intended for patients who have limited financial resources and cannot obtain coverage for Mounjaro through insurance.
Although supported by Eli Lilly, the foundation operates as a separate nonprofit organization. Patients approved through this program may receive Mounjaro at no cost.
This program is generally intended for:
Uninsured patients
Patients whose insurance does not cover Mounjaro
Individuals who meet specific income requirements
Mounjaro Savings Card
The Mounjaro Savings Card is a commercial savings program designed for eligible patients with private or employer-sponsored insurance.
Unlike the patient assistance program, it is not based on income. Instead, it helps reduce copays for patients whose insurance covers Mounjaro or who face high prescription costs.
Eligible patients may pay as little as $25 for a qualifying prescription supply, depending on the current program terms.
Key Differences Between the Two Programs
Program
Intended For
Patient Cost
Lilly Cares Patient Assistance Program
Uninsured or financially eligible patients without Mounjaro coverage
$0 if approved
Mounjaro Savings Card
Commercially insured patients with eligible plans
As low as $25 when eligible
Patients with Medicare, Medicaid, Tricare, or VA coverage are generally not eligible for manufacturer savings cards because of federal restrictions. However, some may still qualify for assistance programs depending on their circumstances.
Who Qualifies for the Mounjaro Patient Assistance Program?
The Lilly Cares Foundation has specific eligibility requirements that applicants must meet before receiving free medication.
Basic Eligibility Requirements
Applicants generally must meet the following criteria:
1. U.S. Residency
Applicants must be U.S. citizens or lawful residents. Proof of residency may be required during the application process.
2. Prescription From a Licensed Healthcare Provider
A valid Mounjaro prescription from a U.S.-licensed healthcare professional is required. The medication must be prescribed as part of appropriate medical care.
3. No Eligible Prescription Coverage
Patients generally must not have prescription insurance coverage that pays for Mounjaro.
This may include:
Individuals without insurance
Patients whose insurance excludes Mounjaro
Patients whose plans do not provide coverage for the medication
Patients with insurance coverage but a high copay are usually better suited for savings programs rather than patient assistance.
4. Income Requirements
The most important financial requirement is household income. Applicants typically must have income at or below a certain percentage of the federal poverty level.
The program evaluates household income, which may include:
Employment wages
Self-employment income
Retirement income
Social Security benefits
Certain investment income
Applicants may need to provide tax documents or income verification forms.
2026 Income Guidelines for Patient Assistance Eligibility
The Lilly Cares program uses income limits based on federal poverty guidelines. The exact threshold depends on household size.
Approximate 400% federal poverty level limits for 2026 include:
Household Size
Estimated Income Limit
1 person
$62,600
2 people
$84,600
3 people
$106,600
4 people
$128,600
5 people
$150,600
6 people
$172,600
Income limits may change annually, so applicants should confirm the latest requirements before submitting documentation.
A household of four earning around $120,000 annually may fall within the income requirements, while a single applicant earning above the individual limit may not qualify.
How to Apply for the Mounjaro Patient Assistance Program
The application process requires information from both the patient and their healthcare provider.
Step 1: Confirm Your Prescription
Before applying, patients must have an active Mounjaro prescription from a healthcare provider.
The assistance program does not replace the medical evaluation process. A provider must first determine whether Mounjaro is appropriate.
Step 2: Complete the Enrollment Application
Applicants must complete the patient assistance enrollment form.
The form typically requires:
Personal information
Contact details
Residency information
Household income details
Patient signature
Step 3: Provide Income Documentation
Applicants may need to submit documents such as:
Recent federal tax returns
W-2 forms
Social Security statements
Pension documentation
Proof of income changes, if applicable
Patients without income may need to provide a signed statement explaining their situation.
Step 4: Healthcare Provider Completes Their Section
The prescribing healthcare provider must provide:
Prescription details
Medication information
Dosage instructions
Provider signature
This confirms that the medication is medically prescribed.
Step 5: Submit the Application
Applications can generally be submitted through available program submission methods, including:
Fax
Mail
Electronic submission through provider systems
Step 6: Wait for Review
Applications are usually reviewed after all required documents are received.
A decision may be provided within several business days, although incomplete applications may take longer.
What Happens After You Apply?
After review, applicants usually receive one of three outcomes.
Approval
If approved:
Patients receive confirmation of enrollment
Medication shipments begin according to program procedures
Assistance generally lasts for a limited period, often up to one year
Patients typically need to reapply if they continue requiring assistance after the approval period ends.
Request for Additional Information
Some applications require more documentation before a final decision can be made.
Common requests include:
Updated income records
Missing signatures
Additional prescription details
Responding quickly can prevent unnecessary delays.
Denial
Applications may be denied for reasons such as:
Income above program limits
Existing qualifying insurance coverage
Missing documentation
Incomplete provider information
Patients can review the reason for denial and may reapply if their situation changes.
Understanding the Mounjaro Savings Card Option
For patients with commercial insurance, the savings card may provide a better solution than patient assistance.
Key features include:
Available for eligible commercially insured patients
Does not usually require income verification
Helps reduce prescription copays
Cannot generally be combined with other discount programs
A common misunderstanding is that the savings card applies to every Mounjaro prescription. Eligibility depends on insurance status and the approved use of the medication.
Patients using tirzepatide specifically for weight management may need to explore programs associated with the medication’s weight-management indication rather than diabetes treatment.
What If Your Application Is Denied?
A denial does not always mean there are no remaining options.
Patients can consider several alternatives.
Review and Correct Application Errors
If incorrect information or missing documents caused the denial, submitting corrected information may help.
Explore Independent Assistance Programs
Some nonprofit organizations provide medication assistance based on income, diagnosis, and available funding.
Eligibility varies, and programs may open or close depending on funding availability.
Consider Insurance Appeals
If insurance coverage was denied, patients may work with their healthcare provider to submit an appeal.
Supporting documentation may include:
Medical history
Previous treatment attempts
Provider statements
Clinical justification
Discuss Alternative Treatment Options
If Mounjaro remains unaffordable, healthcare providers may discuss other treatment options that fit the patient’s medical needs and financial situation.
How Much Does Mounjaro Cost Without Assistance?
Without insurance coverage or assistance, Mounjaro can be expensive.
Approximate cost differences:
Situation
Possible Cost
Retail cash price
Around $1,000+ per month
Eligible savings program
Potentially reduced copay
Approved patient assistance
$0 cost
For qualifying patients, assistance programs can create a significant financial difference compared with paying the full retail price.
Tips to Improve Your Chances of Approval
To make the application process smoother:
Gather income documents before applying
Ensure all forms are signed and complete
Confirm your prescription information is accurate
Ask your healthcare provider’s office for assistance
Respond quickly if additional information is requested
Keep copies of submitted documents
A complete application is less likely to experience delays.
Conclusion
The Mounjaro Patient Assistance Program can provide an important pathway for eligible patients who cannot afford their medication. By understanding the difference between charitable assistance programs and commercial savings options, patients can choose the approach that best matches their insurance status and financial situation.
Eligibility requirements, income limits, and program terms can change over time, so reviewing current information and working closely with a healthcare provider is essential. For many qualified patients, these programs can make access to Mounjaro more realistic and reduce the financial burden of long-term treatment.
Sources
Lilly Cares Foundation. Patient Assistance Program eligibility and enrollment materials. Accessed 2026.
U.S. Department of Health and Human Services. Federal Poverty Guidelines. 2026.
Eli Lilly and Company. Mounjaro Prescribing Information. Updated 2024.
U.S. Food and Drug Administration. Mounjaro (tirzepatide) approval letter and label. 2022.
Inflation Reduction Act of 2022, Public Law 117-169, Medicare Part D out-of-pocket cap provisions.
Centers for Medicare and Medicaid Services. Anti-kickback statute and prescription drug copay assistance guidance.
NeedyMeds. Patient assistance program directory. Accessed 2026.
Frias JP, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2). N Engl J Med. 2021;385:503-515.
Similar Blog Posts
All articles9/7/2026
How to Evaluate Peptide Vendors and Avoid Common Red Flags
Read Article9/7/2026
How to Choose a Reliable Research Peptide Vendor: A Complete Guide to COAs, Lab Testing, and Transparency
Read Article9/1/2026